fludeoxyglucose f-18

Generic: fludeoxyglucose f-18

Labeler: brigham and women`s hospital, inc., the
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fludeoxyglucose f-18
Generic Name fludeoxyglucose f-18
Labeler brigham and women`s hospital, inc., the
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

fludeoxyglucose f-18 300 mCi/mL

Manufacturer
BRIGHAM AND WOMEN`S HOSPITAL, INC., THE

Identifiers & Regulatory

Product NDC 24450-647
Product ID 24450-647_21bdce90-ba9a-4304-876b-79a11840d532
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203816
Listing Expiration 2026-12-31
Marketing Start 2014-10-30

Pharmacologic Class

Established (EPC)
radioactive diagnostic agent [epc]
Mechanism of Action
radiopharmaceutical activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24450647
Hyphenated Format 24450-647

Supplemental Identifiers

UNII
0Z5B2CJX4D
NUI
N0000177914 N0000000205

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fludeoxyglucose f-18 (source: ndc)
Generic Name fludeoxyglucose f-18 (source: ndc)
Application Number ANDA203816 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 300 mCi/mL
source: ndc
Packaging
  • 30 mL in 1 VIAL, MULTI-DOSE (24450-647-30)
source: ndc

Packages (1)

24450-647-30 30 mL in 1 VIAL, MULTI-DOSE (24450-647-30)

Ingredients (1)

fludeoxyglucose f-18 (300 mCi/mL)

Linked Drug Pages (1)

FLUDEOXYGLUCOSE F-18 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "21bdce90-ba9a-4304-876b-79a11840d532", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["6b7b71c9-f10c-4ace-8166-ea242d8e628d"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["BRIGHAM AND WOMEN`S HOSPITAL, INC., THE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (24450-647-30)", "package_ndc": "24450-647-30", "marketing_start_date": "20141030"}], "brand_name": "FLUDEOXYGLUCOSE F-18", "product_id": "24450-647_21bdce90-ba9a-4304-876b-79a11840d532", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "24450-647", "generic_name": "FLUDEOXYGLUCOSE F-18", "labeler_name": "BRIGHAM AND WOMEN`S HOSPITAL, INC., THE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FLUDEOXYGLUCOSE F-18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203816", "marketing_category": "ANDA", "marketing_start_date": "20141030", "listing_expiration_date": "20261231"}